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LarynxAbstract Purpose: To examine the potential of dynamic contrast enhanced magnetic resonance
imaging (DCE-MRI), diffusion weighted imaging (DWI) and apparent diffusion coefﬁcient
(ADC) for differentiating recurrent laryngeal cancer from post treatment changes.
Materials and methods: A prospectively designed study was conducted on 50 patients having laryn-
geal cancers treated by surgery or chemoradiotherapy or both. In all subjects, conventional MRI
sequences were performed apart from DWI and DCE sequences. Mean ADC values in benign
and malignant groups were compared. Different patterns of dynamic curves were compared qualita-
tively and semiquantitatively using washout ratio (WR), time to peak (Tpeak) and maximum con-
trast enhancement in both groups.
Results: ADC cutoff value of 0.9667 · 103 mm2/s effectively differentiated benign and malignant
lesions with 100% sensitivity, 74.2% speciﬁcity and 84% accuracy. Mean WR in benign or inﬂam-
matory lesions was signiﬁcantly lower than in malignant tumors. A cutoff value of WR 7.995 can
differentiate benign post treatment changes from malignant recurrence with sensitivity of 96.6%,
speciﬁcity of 81.2% and overall accuracy of 88.9%.
380 S. Desouky et al.Conclusions: ADC mapping and DCE MRI are effective MRI tools for the differentiation of
benign post treatment changes from malignant recurrence in laryngeal cancer.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
At the time of diagnosis of head and neck cancers, the
majority of these patients present with locoregionally
advanced disease and require an ampliﬁed and aggressive
treatment regime consisting of neoadjuvant therapy and
extended surgery (1). After surgery, normal anatomic
structures can be extensively distorted. The use of radiation
therapy renders physical examination, CT, and MR imaging
unreliable because of the edema and ﬁbrosis that are often
present after treatment. Also, the differentiation between
tumor recurrence and laryngeal necrosis can be challenging
after radiotherapy (2).
The role of MRI for differentiating recurrent tumor from
ﬁbrosis after treatment of head and neck carcinoma was previ-
ously investigated (3). Recurrent tumors were found to demon-
strate higher signal intensity on T2-weighted images than
ﬁbrotic benign changes do. However, further studies have
shown that non neoplastic inﬂammation or edema may also
be responsible for T2 hyperintensity and that this ﬁnding is
nonspeciﬁc (3).
Dynamic contrast enhanced MRI (DCE-MRI) is valu-
able for the differentiation of tumor recurrence and post
treatment ﬁbrosis in regions such as the breast, pelvis, gas-
trointestinal and musculoskeletal system (4,5). Dynamic
contrast enhanced MRI enables the quantitative assessment
of tumor status and has found application in pre-clinical
tumor models as well as clinical oncology. DCE-MRI
requires the serial acquisition of images before and after
the injection of a paramagnetic contrast agent so that the
variation of MR signal intensity with time can be recorded
for each image voxel. As the agent enters into a tissue, it
changes the MR signal intensity from the tissue to a degree
that depends on the local concentration (6). Dynamic
contrast enhanced magnetic resonance imaging is a useful
clinical tool in evaluation of soft tissue neoplasm and
lymph nodes in head and neck. It is thought to be a useful
predictor of response to radiotherapy for head and neck
carcinoma and used to monitor the treatment and distin-
guish post therapeutic changes from recurrent mass with
greater conﬁdence (7,8).
Diffusion weighted imaging (DWI) is able to characterize
tissue based on differences in water mobility. DWI and
apparent diffusion coefﬁcient (ADC) measurements are being
considered as potentially useful in the evaluation and charac-
terization of head and neck lesions (9). DWI plays an impor-
tant role in the diagnosis, prognosis and monitoring of
treatment response in tumors arising in the head and neck
region (10). It is able to distinguish between the viable and
necrotic portions of head and neck tumors. Also, DWI is
indicated for characterizing lesions in children avoiding the
use of contrast (11). Hypercellular tissue, such as occurring
within malignant tumors, will show low ADC values.
Nontumoral tissue changes such as odema, inﬂammation,ﬁbrosis, and necrosis are expected to show low cellularity,
in strong contrast with viable tumor. This results in a high
ADC. An inverse correlation between the ADC value and
tumor cellularity in experimental models has been shown,
and this has been clinically validated (12,13). The ADC maps
exhibit a high sensitivity (94.6%), speciﬁcity (95.9%) and
accuracy (95.5%) in the discrimination of tumoral and non-
tumoral tissues (14).
The aim of this work was to investigate the value of dynam-
ic contrast enhanced magnetic resonance time intensity curve,
DWI and ADC map in the differentiation of post treatment
changes from recurrent laryngeal carcinoma.
2. Material and methods
2.1. Patients
From September 2011 to September 2014, the study was
carried out on 50 patients clinically suspected of recurrent
laryngeal cancer after surgery, radiation therapy or che-
motherapy, or both, and referred to Radio-diagnosis
department of our institution University Hospital. The
MR diagnoses were correlated with histologic ﬁndings from
biopsy or, in some cases, with clinical follow-up. The
patients are examined either in the immediate post treat-
ment interval or further according to the clinical complaint
and situation.
The protocol of this prospective study was approved by
the ethics committee of our medical institution, and an
informed consent was obtained from all patients prior to
the study.
Patients included 49 males (98%) and 1 female (2%) with
ages ranging from 30 to 98 years. In ﬁve patients, there were
no readings for the TICs as in two patients there was sus-
ceptibility artifact in DCE sequence hindering identiﬁcation
of the lesion (peristomal and subglottic nodules) and in
three patients the lesions were not enhancing (one purely
cystic lymph node, one cystic peristomal lesion and one
ﬁbrosis at the proximal suture line of the reconstructed
neopharynx).
Final diagnoses were conﬁrmed by either diagnostic laryn-
goscopy and biopsy in 12 patients (26%), FNA in 29 patients
(58%), open biopsy in one patient having radical neck dissec-
tion after FNA or by clinical follow-up in nine patients (18%).
Clinical follow-up for one year was considered as post treat-
ment changes if no change or decrease in the size of the lesion
under question and no new lesions appeared and considered as
malignant recurrence if the lesion increased in size or new
lesions appeared.
MR images were performed on a 1.5T system (Achieva
1.5T A-series, Philips Medical Systems) by using a 16 channel
sense neurovascular head and neck coil. All patients under-
went DWI and DCEMRI examinations in addition to conven-
tional MRI.
Fig. 1 Showing the different types of TICs.
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T1 and T2WI were obtained before application of the contrast
material, as well as fat suppressed (STIR) T2WI. Delineation
of tumor from healthy tissue was aided by using fat saturated
contrast enhanced T1WI. This sequence was obtained follow-
ing the DCE sequence. The patient study consisted of MR
imaging covering the entire neck. The standard MR acquisi-
tion parameters were as follows: rapid scout images, multipla-
nar (axial, coronal, and sagittal) T2-weighted images, axial T2
fat-suppressed fast spin-echo images (TR, 5000 ms; TE,
102 ms; averages, 2; matrix, 256 · 256; section thickness,
5.0 mm; and gap, 2.5 mm) and axial T1-weighted images
(TR, 675 ms; TE, 8 ms; averages, 2; section thickness,
5.0 mm; gap, 2.5 mm; matrix, 256 · 256). Standard T1- and
T2-weighted imaging was followed by DWI. After DWI, Gd-
DTPA contrast agent was injected and DCE and postcontrast
multiplanar T1-weighted images were acquired.
Characterization of the lesion in conventional MRI was
based upon morphological criteria regarding tumor volume,
signal intensity (SI) in different sequences and enhancement
after Gd-DTPA. Areas with very high SI (equivalent to water)
in T2-weighted images were regarded as necrosis or cystic
degeneration andmarkedly hypointense (similar to themuscles)
areas in T1- and T2-weighted images were regarded as ﬁbrosis.
Tumors were considered as iso to hypointense lesions in T1 and
T2WI with positive mass effect on the surroundings enhancing
after contrast injection. Regarding lymphadenopathy, certain
parameters (round or globular shape, size more than 10 mm
in short axis, internal heterogeneity, extracapsular extension,
and vascular invasion) are associated with nodal recurrence.
2.3. DWI MRI
DWI was performed by using a single shot spin echo EPI
sequence with the following parameters: axial plane 4-mm sec-
tion thickness, FOV of 240 mm, and b-values of 0 and 1000 s/
mm2. ADC maps were generated from the DWIs where ROIs
placed on the DWIs were copied to the corresponding ADC
map and ADC values were calculated using the workstation
software. ROIs were placed upon solid portions of the lesion
avoiding necrotic areas. Three ADC values were calculated
and the mean ADC was the value used in statistical analysis.
The mean ADC values in the benign and malignant groups
were compared using Mann–Whitney U-test. Lesions in
DWI were evaluated qualitatively as being hyperintense or
hypointense and statistical signiﬁcance was assessed using
Fisher’s Exact test.
We used the receiver operating characteristic (ROC) curve
to evaluate the diagnostic capability of the mean ADC value
for differentiation between malignant recurrence and post
treatment changes in cancer larynx, and then we used multiple
thresholds of mean ADC values in order to select the best one
(cutoff value) for differentiating benign from malignant
lesions. The probability (p value) was considered signiﬁcant
when P 6 0.05.
2.4. DCE MRI
Gadolinium (Meglumine Gadopentetate, Magnevist) was
injected intravenously at a dose of 0.1 ml/kg body weightand at an injection rate of 2 ml/s, followed by a 20 ml saline
ﬂush. In each patient, 10 scans were obtained sequentially
(around 38 s for each scan with a total of about 6.3 min).
Gadolinium enhanced MRI was performed based on institu-
tional guideline that gadolinium should not be used in patients
with creatinine clearance less than 30 ml/min unless clinically
indicated. It was performed using a three dimensional, spoiled
gradient recalled echo (3D-SPGR) sequence (5 ms repetition
time (TR); 1.4 ms echo time (TE); 15 ﬂip angle; 5 mm section
thickness; 240 mm ﬁeld of view (FOV); 265 · 265 mm matrix
size).
2.4.1. TIC analysis
The sequential dynamic MR images in a DICOM format
were transferred onto an extended MRI workspace; Philips
workstation using its software. Once a ROI was manually
placed onto a lesion area so that it included as much diseased
area as possible, the same ROI was automatically placed onto
the subsequent 10 dynamic MR images by automatically
copying and pasting the initial ROI by using this software.
ROIs were placed in the solid most enhancing portion of
the lesion avoiding necrotic areas. Then, TIC was generated
automatically using the software including its analysis. Each
of the obtained TIC was classiﬁed qualitatively into 3 types
(types 1–3).
The different TIC patterns were qualitatively referred to as:
type 1 (continuous rising curve), type 2 (rapid uptake with gra-
dual washout) and type 3 (rapid uptake with rapid washout)
(Fig. 1). The different types of curves in the benign and malig-
nant groups were compared using the Chi-Square test.
Semiquantitative evaluation of the TIC was done using TIC
parameters. These parameters were calculated by the following
equations: The contrast index (CI %) = (signal intensity
(post-contrast) – signal intensity (pre-contrast))/signal intensi-
ty (pre-contrast) · 100. Tpeak is the time required to reach the
ﬁrst contrast index peak in seconds; and WR %= ((contrast
index at Tpeak) – (contrast index at 360 s from the start of
contrast medium injection))/(contrast index at Tpeak) · 100.
Contrast index at Tpeak is referred to as ‘‘CI max %’’ and
contrast index at 360 s after the start of contrast medium injec-
tion is referred to as ‘‘CI 360%’’ (Fig. 2). The different para-
meters in the benign and malignant groups were compared
using Mann–Whitney U-test.
We used the receiver operating characteristic (ROC) curve
to evaluate the diagnostic capability of the washout ratio for
differentiation between malignant recurrence and post treat-
ment changes in cancer larynx, and then we used multiple
thresholds of mean washout ratio values in order to select
the best one (cutoff value) for differentiating benign from
malignant lesions. The probability (p value) was considered
signiﬁcant when P 6 0.05.
Fig. 2 Showing the different parameters derived from the TIC;
CImax, CI360 and Tpeak.
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Data were statistically described in terms of mean ± standard
deviation (±SD), and frequencies (number of cases) and per-
centages when appropriate. Comparison of numerical vari-
ables between the study groups was done using Student’s t
test for independent samples. For comparing categorical data,
Chi square test was performed. Exact test namely Fisher’s
Exact test was used instead when the expected frequency is less
than 5. Accuracy was represented using the terms sensitivity,Table 1 Results of MRI diffusion and TIC among the studied patie
Clinical characteristics Malignant lesions (n= 31)
No. %
Diﬀusion [n= 50] [n= 31]
Hyper-intense 31 100.0
Hypo-intense 0 0.0
Mean ADC value [n= 50]
Min–Max 0.73–1.73
Mean ± SD 0.91 ± 0.18
Type of curve [n= 45] [n= 29]
Malignant 29 100.0
Benign 0 0.0
CI max [n= 45]
Min–Max 7.9–87.5
Mean ± SD 44.5 ± 15.1
CI 300 [n= 45]
Min–Max 4.7–87.3
Mean ± SD 42.9 ± 14.9
Time to peak [n= 45]
Min–Max 50.0–90.0
Mean ± SD 72.3 ± 8.7
Washout ratio [n= 45]
Min–Max 29.5 – 40.5
Mean ± SD 4.2 ± 10.9
FEP: Fisher’s Exact test.
X2: Chi-Square test.
Z: Mann–Whitney U-test.
* Signiﬁcant at P 6 0.05.and speciﬁcity. Receiver operator characteristic (ROC) analy-
sis was used to determine the optimum cutoff value for the
studied diagnostic markers. P values less than 0.05 were con-
sidered statistically signiﬁcant. All statistical calculations were
done using computer programs SPSS (Statistical Package for
the Social Science; SPSS Inc., Chicago, IL, USA) version 15
for Microsoft Windows.
3. Results
This study included 50 patients presenting to our institution
with clinically suspected recurrent laryngeal cancer. Patients
included 49 males (98%) and 1 female (2%). Their ages ranged
from 30 to 70 years, Mean age = 59.4 years, SD = 9.6.
Eight patients were operated only (16%), 20 patients (40%)
operated followed by chemoradiotherapy, eight patients (16%)
operated followed by radiotherapy, one patient (2%) operated
followed by chemotherapy, 12 patients (24%) received only
chemoradiotherapy and one patient (2%) received only
radiotherapy.
By conventional MRI, we had 21 patients (42%) suspected
of local laryngeal recurrence (supraglottic, glottic or subglottic
or recurrence of the reconstructed neopharynx), six patients
(12%) suspected of stomal recurrence (around the tracheosto-
my opening) and 23 patients (46%) suspected of nodal recur-
rence (upper or lower deep cervical or submandibular groups).
Pathological diagnosis following diagnostic laryngoscopy
revealed three postirradiation ﬁbroses (6%) and nine (18%)nts with recurrent laryngeal tumors and post treatment changes.
Benign lesions (n= 19) Signiﬁcance
No. %




1.47 ± 0.29 P< 0.0001*
[n= 16]
0 0.0 X2 = 45.0
16 100.0 P< 0.0001*
12.0–75.5 Z= 0.95
38.4 ± 21.6 P= 0.342
18.6–104.3 Z= 0.249
53.1 ± 31.4 P= 0.803
37.6–90.2 P= 0.887
70.3 ± 13.2
120.0 – 29.8 Z= 4.048
46.3 ± 46.5 P< 0.0001*
Table 2 Mean ADC value and cutoff point to diagnose post treatment changes from recurrent tumors.
AUC Cutoﬀ point Sensitivity Speciﬁcity PPV NPV Accuracy
Mean ADC value 0.952 0.9667 100.0% 74.2% 70.4% 100.0% 84.0%
ROC Curve













Fig. 3 ROC curve of mean ADC value to diagnose benign
lesions.
ROC Curve













Fig. 4 ROC curve of washout ratio to diagnose malignant
lesions.
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revealed ﬁve reactive lymph nodes (10%) and 18 nodal squa-
mous cell carcinoma recurrences (36%). FNA of the stomal
lesions revealed one postoperative granulation tissue, one
inﬂammatory cyst and four recurrent squamous cell carcino-
mas. Biopsy of right lower deep cervical lesion after radical
neck dissection was negative of malignant cells, and only
granulation tissue, this was against the FNA specimen (false
positive by FNA). On clinical follow-up of nine patients for
one year, there was improvement as regards the size of the sus-
pected lesion and no new lesions or complaints (four nodular
swellings of the reconstructed neopharynx, two supraglottic
lesions and three glottic lesions).
3.1. DWI and overall ADCs
ADCs of recurrent lesions (mean ADC 0.91 ± 0.18 ·
103 mm2/s) were signiﬁcantly lower than those of post treat-
ment changes (mean ADC 1.47 ± 0.29 · 103 mm2/s) (p-value
= P< 0.0001, signiﬁcant if P 6 0.05) (Table 1). An ADC cut-
off point of 0.9667 · 103 mm2/s was best for differentiating
post treatment changes from malignant tumors; it provided
100% sensitivity and 74.2% speciﬁcity (Table 2). Fig. 3 is
the ROC curve of Mean ADC value to diagnose benign
lesions.Table 3 Cutoff point of washout ratio to diagnose post treatment
AUC Cutoﬀ point Sensitivity
Washout ratio 0.867 7.995 96.6%3.2. TICs
Regarding Tpeak, there was no statistically signiﬁcant differ-
ence between recurrent tumors and post treatment changes
(p-value = P= 0.887) (Table 1). The mean Tpeak in post
treatment changes was 70.3 ± 13.2 and in malignant tumors
was 72.3 ± 8.7.
Similarly, no statistically signiﬁcant difference was found
between recurrence or post treatment changes regarding CI
max and CI 360. The mean CI max in benign lesions was
38.4 ± 21.6 and in malignant tumors was 44.5 ± 15.1 (p-val-
ue = 0.342). The mean CI 360 in benign lesions was
53.1 ± 31.4 and in malignant tumors was 42.9 ± 14.9 (p-val-
ue = 0.803) (Table 1).
The WR in benign lesions was 46.3 ± 46.5 and in malig-
nant tumors was 4.2 ± 10.9. This showed statistical sig-
niﬁcance (P< 0.0001) (Table 1). A washout cutoff point of
7.995 was best for differentiating benign lesions from malig-
nant tumors; it provided 96.6% sensitivity and 81.2% speciﬁci-
ty (Table 3). Fig. 4 is the ROC curve of washout ratio to
diagnose malignant lesions.
Regarding qualitative assessment of the shape of the curve,
in all patients with TICs we found three types of curves, types
1, 2 and 3. Type 1 curve was found in benign postirradiation orchanges from recurrent tumors.
Speciﬁcity PPV NPV Accuracy
81.2% 90.3% 92.9% 88.9%
384 S. Desouky et al.postoperative lesions in 17 patients (34%) and type 2 curve
was found in recurrent malignant lesions (either local or nodal
recurrence) in 31 patients (62%). Type 3 curve was found only
in two patients (4%): one patient had suspected nodal recur-
rence that proved to be inﬂammatory lymph node and theFig. 5 Male patient 60 years old with anaplastic SCC of the larynx,
Now complaining of left lower neck swelling proved by FNA to be an
there is left lower deep cervical lymph node (white arrows) hypointens
node is hyperintense becoming hypointense in ADC map (D) with AD
DCE sequence and washout ratio of 6.7.other patient had focal thickening of the reconstructed
neopharynx that proved to be postirradiation thickening. So,
type 3 curve was found in benign lesions. Qualitative assess-
ment showed statistical signiﬁcance in differentiating benign
and malignant lesions P< 0.0001 (Table 1).managed by total laryngectomy and received chemoradiotherapy.
aplastic carcinoma in nodal recurrence. In axial T2 (A) and T1 (B)
e in T1 and of intermediate intensity in T2. In DWI (C) the lymph
C value of 0.9 · 103 s/mm2. (E) TIC type 2 is generated from the
Fig. 6 60 years male having right glottic cancer managed by chemoradiotherapy, last session since 6 months. Now complaining of new
hoarseness of voice proved by endoscopic examination and follow-up to be postirradiation changes. In axial T2 (A), there is a right glottic
hypointense mass with marked enhancement after contrast injection (B). In DWI, the lesion is hyperintense and in ADC map, the ADC
value is 1.5 · 103 s/mm2. In DCE sequence, the curve is type 1 and washout ratio 69.2.
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examples of lesions encountered in the study are shown in
Figs. 5–8.
4. Discussion
Imaging surveillance after treatment of laryngeal squamous
cell carcinoma is useful to detect residual or recurrent tumor,
even when clinical recurrence is not suspected (15). In these
patients, however, the multidisciplinary treatment with sur-
gery, radiation therapy, and/or chemotherapy that improves
patient survival and quality of life complicates interpretation
of post treatment follow-up imaging studies because surgery
can alter anatomy and radiation therapy and chemotherapy
can result in edema and ﬁbrosis (16). These post treatment
changes can mimic tumor recurrence, and sometimes it is dif-
ﬁcult to distinguish these from residual or recurrent tumor
on CT or MR images (17).Our results showed that qualitative evaluation of the DWI
is statistically signiﬁcant in differentiating post treatment
changes and recurrent laryngeal cancer (either local or nodal
recurrence). Quantitative assessment using the ADC map
showed the mean ADC value of post treatment changes
(1.47 ± 0.29 · 103 mm2/s) to be signiﬁcantly higher than that
of malignant recurrence (0.91 ± 0.18 · 103 mm2/s). The best
ADC cutoff value to differentiate benign from malignant
lesions was 0.9667 · 103 mm2/s, with 100% sensitivity, 74.2%
speciﬁcity, 70.4% positive predictive value, 100% negative pre-
dictive value and 84.0% accuracy. This was in agreement with
the results of Vandecaveye et al. (2), in a study for Evaluation
of the larynx for tumor recurrence by diffusion weighted MRI
after radiotherapy.
Our results demonstrated that ADC value had a similar
diagnostic performance compared with a previous study by
Abdel Razek et al. (18), and that the mean ADC in the post
treatment changes group was signiﬁcantly higher than that of
Fig. 7 45 years male having cancer larynx and managed by total laryngectomy and right sided modiﬁed neck dissection since 1.5 years.
Now he is complaining of right neck swelling which proved by FNA to be recurrent SCC and the patient did radical neck dissection after
which the pathology report was negative for malignant cells. Axial T1 (A) and STIR (B) images show a right supraclavicular lesion
hypointense in T1 and intermediate signal in STIR. The lesion is hypointense in DWI (C) and ADC value (D) 1.3 · 103 s/mm2. In DCE
sequence (E), the lesion exhibited type 1 curve and washout ratio 42.2 reﬂecting its benign nature.
386 S. Desouky et al.the recurrent tumor group. The optimal ADC cutoff value to
distinguish between recurrent tumor and postoperative
changes (0.9667 · 103 mm2/s) is slightly lower than that pro-
duced by Abdel Razek et al. (1.30 · 103 mm2/s) (18). In a
study by Hwang et al. (15), the optimal ADC cutoff value
was 1.460 · 103 mm/s. The sensitivity, speciﬁcity, and accura-
cy were 85.0%, 84.6%, and 84.8% respectively. The relatively
high ADC values for residual lesions in their studies could be
due to the edema and small areas of liquefactive necrosis
induced by radiation. Another contributing factor for the
increased ADC in their studies could be the diverse patholo-
gies compared with the more homogenous pathology in our
work.
In a study by OssamaHassan et al. (19), they found that DW
MRI presents high sensitivity (100%), Positive predictive value
(75%), Negative predictive value (100%), accuracy (85%) and
less speciﬁcity (71%) than PET/CT (68% sensitivity, 70%
Positive predictive value, 83% Negative predictive value, 78%accuracy and 84% speciﬁcity) in the preoperative evaluation
of clinically N0 neck in cases of HNSCC. In a study by Lee
et al. (20), the ADC cutoff value was (0.851 · 103 mm2/s) for
the detection of malignant head and neck lymph nodes with
91.3% sensitivity and 91.1% speciﬁcity. This cutoff value is
slightly lower than our results (0.9667 · 103 mm2/s). This may
be due to the fact that we used b-values of 0 and 1000, a much
higher b2 factor than that in the study by Lee et al. besides, them
using 3 TMRI unit. Different MR imaging units may also have
different ranges of ADC values.
Dynamic contrast enhanced imaging (DCE-MRI) produces
information about the vascularity of cancers and has the poten-
tial to be used to detect and characterize tumors, and evaluate
treatment response (21). In head and neck cancers DCE-MRI
has been reported as a potential tool for identifying primary
tumors and metastatic nodes, differentiating benign from
malignant tumors (22), and monitoring the treatment response
(23). In this study we evaluated DCE sequence qualitatively
Fig. 8 49 years male with cancer larynx managed by total laryngectomy and radiotherapy, last session since 1 year. Now, he is
complaining of right submandibular swelling that proved by biopsy to be inﬂammatory lymph node and disappeared by medical
treatment. A hypointense right submandibular lymph node is noted in T2 (A) and T1 (B) WI which is hyperintense in DWI (C)
and ADC value 1.2 · 103 s/mm2 (D). In DCE sequence, the curve is type 3 and washout ratio 37.7 reﬂecting the benign nature
of the lesion.
Role of dynamic contrast enhanced and diffusion weighted MRI 387using the shape of TIC and semiquantitatively by analyzing the
parameters: Tpeak, CI max, CI 360 and WR.
Our results showed that qualitative assessment of the shape
of TIC can signiﬁcantly differentiate between benign post
treatment changes and malignant laryngeal recurrence. Type
1 curve was found exclusively in benign lesions, type 2 curve
was found exclusively in malignant lesions and type 3 curve
was found in benign post treatment lesions.
Jansen et al. (24), found in their study that 68% of malig-
nant curves exhibited ‘‘washout,’’ and benign lesions have
‘‘persistent’’ type curves. These results are in concordance with
ours. Kuhl et al. (25) presented such an approach, in which the
shape of the entire time signal intensity curve is qualitatively
assessed, yielding three different curves: steady, plateau, and
washout. In their patient population, the use of these time sig-
nal intensity curves resulted in dramatically higher speciﬁcity(83%) and accuracy (86%) than were obtained when the
enhancement rate (speciﬁcity, 37%; accuracy, 58%) was used.
Hidetake Yabuuchi et al. (26) in a study of parotid gland
tumors agreed with our results, they regarded types 1 and 3
TIC tumors as benign neoplasms and type 2 TIC tumors as
malignant neoplasms, the sensitivity, speciﬁcity, accuracy,
and positive and negative predictive values were 71%, 86%,
82%, 67%, and 89% respectively.
Semiquantitative analysis of TIC in our study showed that
Tpeak, CImax and CI360 are not statistically signiﬁcant in dif-
ferentiating benign post treatment changes from local or nodal
recurrence. However, washout ratio proved to be signiﬁcant in
differentiating both. A washout cutoff value of 7.995 has
resulted in 96.6% sensitivity, 81.2% speciﬁcity, 90.3% positive
predictive value, 92.9% negative predictive value and 88.9%
accuracy in differentiating benign and malignant lesions.
388 S. Desouky et al.These results are in agreement with those of Olivier Rouvie`re
et al. (27); they stated that there was no difference in maximum
enhancement level and Tpeak in differentiating benign from
malignant prostatic tissue and the contrast washout was sig-
niﬁcantly more rapid in tumor than in normal peripheral zone.
In a study of the role of DCE MRI in radiotherapeutic efﬁcacy
in head and neck tumors, Noriaki Tomura et al. (28), conclud-
ed that maximum slope of increase (which corresponded to
washout ratio in our study) is lower in nontumor involved
lesions and this is in agreement with our results.
Semiquantitative data have the advantage of being simple
to obtain, but are not readily transferable between different
MRI scanners and radiofrequency coils because the baseline
signal from the tissue will vary between systems. In addition,
they do not take into account the underlying T1 value of the
tissue being studied, and do not accurately indicate the tissue
concentrations of gadolinium present (29).
Our study had some limitations. We tried to include all
patients who met the inclusion criteria to minimize selection
bias. In addition, we included laryngeal cancers with various
locations, treatment modalities, and intervals between last
treatment and imaging, and this heterogeneity could limit the
generalizability of our results. Although tumor location is
related to prognosis, we believed that any signiﬁcant impact
of tumor location relative to ADC values and DCE parameters
was unlikely. Another limitation of our present study was that
the selection of optimal sites for data sampling and localization
of ROIs would affect the consistent acquisition of reliable
ADC values and TICs. The reproducibility of ADC values
between MR pulse sequences remains controversial. As such,
the cutoff level for the ADC value derived from our results
might not be transferable to other institutions.
5. Conclusions
ADC mapping and DCE MRI are effective MRI tools for the
differentiation of benign post treatment changes from malig-
nant recurrence in laryngeal cancer. Based on our results,
our recommendation is to imply DWI and DCE MRI whenev-
er there is evaluation of post treatment laryngeal cancer that
remains unsolved by conventional imaging techniques.
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